If labs change: which compound drove it
Correia O, Delgado L, Roujeau JC, Le Cleach L, Fleming-Torrinha JA (2002) Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples
P21 specifically targets mechanisms of neurogenesis and neuroplasticity with a cleaner pharmacological profile than the multi-peptide Cerebrolysin
When a pause is warranted, daily formulations usually stop the day of the procedure, while weekly injectables stop about a week out
429 Precision medicine guided by genetic insights holds promise for tailoring hyperuricemia management to individualized needs
Referencias Haufroid, V., Lauwerys, R